21-valent pneumococcal vaccine

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

Korea Aerospace Industries Ltd. (KAI) announced on Monday it has participated in Defense & Security 2023 exhibition in Bangkok, ThailandThe comp...

Indonesia, a partner of South Korea’s KF-21 fighter jet development project, has failed again to notify the Korean government of its plan to p...

KB Financial Group Inc., South Korea’s top financial holding company by assets, on Tuesday reported better-than-expected net profit in the thi...

South Korean venture capitalists are actively discovering attractive investment assets overseas to find a breakthrough amid a prolonged local VC dro...

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

South Korea's automotive parts maker Hyundai Mobis is boosting its presence in North America by unveiling technologies tailored for the market such ...

South Korea's state-run postal service agency Korea Post announced on Wednesday that it will issue 1.28 million commemorative stamps featuring two o...

Korea Aerospace Industries Ltd. (KAI) announced on Wednesday that it is participating in the MSPO International Defence Industry Exhibition in Kielc...

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

Speculative investors in South Korea have started to amass shares related to Mxene, touted as a next-generation material, after dumping a large numb...

SK Group, South Korea’s second-largest conglomerate, has been dedicated to its “Deep Change” initiative since Group Chairman Chey ...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

South Korea’s logistics-to-trading conglomerate LX Group is expected to join the race for the country’s No. 1 shipping company HMM Co. i...

Flight routes between South Korea and China, once Korean flag carriers’ most lucrative, have become their white elephant as passengers on the ...

South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...

South Korea’s headline inflation dropped for a fifth straight month to a 21-month low, adding to expectations that the central bank might not ...

An export conference for South Korean content this week in Jakarta, Indonesia, targeted the Southeast Asian market's population of 600 million.The I...

South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...

ActionPower Corp. founded in 2016 is small and young compared to Big Tech companies or heavily funded startups like OpenAI but it is mighty enough t...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...